First Western Trust Bank’s AstraZeneca AZN Stock Holding History

First Western Trust Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,997	Closed	-$367K	–	206
2025 Q4	$367K	Buy	1,997 +75	+4%	+$13.2K	0.02%	146
2025 Q3	$295K	Hold	1,922	–	–	0.01%	159
2025 Q2	$269K	Sell	1,922 -241	-11%	-$33.8K	0.01%	167
2025 Q1	$318K	Sell	2,163 -676	-24%	-$97.8K	0.02%	147
2024 Q4	$372K	Sell	2,839 -318	-10%	-$44.5K	0.02%	145
2024 Q3	$492K	Buy	3,157 +20	+0.6%	+$3.23K	0.02%	128
2024 Q2	$489K	Buy	3,137 +21	+0.7%	+$3.16K	0.02%	119
2024 Q1	$422K	Buy	3,116 +85	+3%	+$11.3K	0.02%	137
2023 Q4	$408K	Buy	+3,031	New	+$394K	0.02%	141

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

First Western Trust Bank's AZN Position: Q1 2026 in Review

First Western Trust Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,997 shares — an estimated $367K sold.

First Western Trust Bank first reported a position in AZN in Q4 2023 and held it in 9 quarters. The position peaked at $492K in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

First Western Trust Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
First Western Trust Bank sold 1,997 AstraZeneca shares in Q1 2026, an estimated $367K.
First Western Trust Bank first reported a position in AstraZeneca in Q4 2023 and held it in 9 quarters.
First Western Trust Bank's AstraZeneca position peaked at $492K in Q3 2024.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on First Western Trust Bank's 13F filing for Q1 2026, filed 12 May 2026.